Carolinas Wealth Consulting’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-72
Closed -$31.5K 265
2025
Q1
$31.5K Sell
72
-4
-5% -$1.61K 0.01% 397
2024
Q4
$27.7K Buy
76
+3
+4% +$1.25K 0.01% 433
2024
Q3
$37.9K Buy
73
+2
+3% +$1.07K 0.01% 401
2024
Q2
$38.3K Sell
71
-40
-36% -$21.1K 0.01% 402
2024
Q1
$57.4K Buy
111
+43
+63% +$21.4K 0.01% 352
2023
Q4
$32.2K Hold
68
0.01% 392
2023
Q3
$30.7K Buy
68
+15
+28% +$6.8K 0.01% 372
2023
Q2
$23.6K Sell
53
-28
-35% -$12.9K ﹤0.01% 451
2023
Q1
$37.3K Sell
81
-33
-29% -$15.7K 0.01% 405
2022
Q4
$58.5K Buy
114
+20
+21% +$10.2K 0.01% 327
2022
Q3
$43K Buy
94
+23
+32% +$11K 0.01% 347
2022
Q2
$34K Hold
71
0.01% 375
2022
Q1
$35K Buy
71
+20
+39% +$9.14K 0.01% 405
2021
Q4
$24K Hold
51
0.01% 455
2021
Q3
$19K Hold
51
﹤0.01% 477
2021
Q2
$19K Hold
51
﹤0.01% 507
2021
Q1
$18K Buy
51
+5
+11% +$1.61K ﹤0.01% 526
2020
Q4
$15K Sell
46
-37
-45% -$11.4K ﹤0.01% 521
2020
Q3
$22K Buy
83
+47
+131% +$12.6K 0.01% 377
2020
Q2
$10K Buy
+36
New +$9.6K ﹤0.01% 339

Other funds holding ELV

Carolinas Wealth Consulting's ELV Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 72 shares — an estimated $31.5K sold.

Carolinas Wealth Consulting first reported a position in ELV in Q2 2020 and held it in 20 quarters. The position peaked at $58.5K in Q4 2022. 1,589 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 72 Elevance Health shares in Q2 2025, an estimated $31.5K.
  • Carolinas Wealth Consulting first reported a position in Elevance Health in Q2 2020 and held it in 20 quarters.
  • Carolinas Wealth Consulting's Elevance Health position peaked at $58.5K in Q4 2022.
  • 1,589 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.